RE:RE:RE:RE:RE:RE:Consider thisTHobsv wrote: One has to always be looking forward. 90% of biotechs are at a loss is purchased in the last 3 years. This is one that had/has a unique setup where it was undervalued vs. just the core business and had a couple of potentially valuable options to the upside.
Yes, management has been a huge disappointment, and as a result my conviction has fallen.
Reasons not to completely exit now: it's cheap, 2+ year runway with new cash, expect some news on 1902 within the next 6-9 months and I still feel like there is a ~30%+ chance of good news there that could be a game changer.
This episode has me thinking a lot about the Buffet quote "buy a business any idiot can run, because someday one will." Unfortunately no such business exists in biotech.
LOL its even more stunning that you are making excuses. Pis your money away, if you cant learn from mistakes you are what you are.